Ana Laus to Cell Line, Tumor
This is a "connection" page, showing publications Ana Laus has written about Cell Line, Tumor.
Connection Strength
0.310
-
Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, Martin ACBM, do Nascimento Braga Pereira L, de Carvalho CEB, Crovador CS, de Paula FE, Nascimento FC, de Freitas HT, de Lima Vazquez V, Reis RM, da Silva-Oliveira RJ. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024 Jul; 37(4):1170-1183.
Score: 0.162
-
Raquel-Cunha A, Pinheiro J, Marques RF, Font?o P, Cardoso-Carneiro D, Mendes A, Gomes INF, Laus AC, da Silva-Oliveira RJ, Reis RM, Martinho O. RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR-targeted therapies. Mol Oncol. 2025 Nov; 19(11):3205-3222.
Score: 0.044
-
Lengert AVH, Pereira LDNB, Cabral ERM, Gomes INF, Jesus LM, Gon?alves MFS, Rocha AOD, Tassinari TA, Silva LSD, Laus AC, Vidal DO, Pinto MT, Reis RM, Lopes LF. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors. Front Biosci (Landmark Ed). 2022 08 16; 27(8):245.
Score: 0.036
-
da Silva-Oliveira RJ, Gomes INF, da Silva LS, Lengert AVH, Laus AC, Melendez ME, Munari CC, Cury FP, Longato GB, Reis RM. Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines. Int J Mol Sci. 2022 Jul 14; 23(14).
Score: 0.036
-
Souza AG, Bastos VAF, Fujimura PT, Ferreira ICC, Leal LF, da Silva LS, Laus AC, Reis RM, Martins MM, Santos PS, Corr?a NCR, Marangoni K, Thom? CH, Colli LM, Goulart LR, Goulart VA. Cell-free DNA promotes malignant transformation in non-tumor cells. Sci Rep. 2020 12 10; 10(1):21674.
Score: 0.032